A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
Condition: Renal Insufficiency Interventions: Drug: Lanabecestat; Drug: Iohexol Sponsors: Eli Lilly and Company; AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2018 Category: Research Source Type: clinical trials
